Although it is true that there are people who still don't use minimal residual disease (MRD) testing, I think that its use is going to pick up based on results of emerging clinical studies, said Elisabet Manasanch, MD, assistant professor in the Department of Lymphoma/Myeloma and Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center.
Although it is true that there are people who still don't use minimal residual disease (MRD) testing, I think that its use is going to pick up based on results of emerging clinical studies, said Elisabet Manasanch, MD, assistant professor in the Department of Lymphoma/Myeloma and Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center.
Transcript
How widely should MRD testing be occuring? It’s not happening everywhere, but should it be?
Well, as with all new things in medicine, it takes a little bit to break through. So, people have been talking about minimal residual disease in myeloma for 10 years, but we do have more and more data showing that it does correlate with our clinical outcomes. So, it's not been until very recently, probably the last couple of years, 2 to 3 years that we've had actually major studies that have used minimal residual disease testing in their outcomes showing that the patients that are negative do better than the ones that are positive, so this is very, very recent. Although it is true there are people who still don't use it, I think that the use is going to pick up just because every time we have more and more data.
There are presentations here about that, there’s a presentation of another meta-analysis that was published here a couple years ago—it's being updated with more follow-up and showing the same thing that it predicts how long once your negative. If you're negative, your interval free of myeloma will be longer than if you're positive, for example. Also, how long you survive with this disease will also be longer if you're negative than positive. This is just confirming these things. So, I think that some of the barriers are basically just making people aware, making patients aware, making physicians in the community aware that this is a test that is available. Especially commercially, if they do not have access to a test that they can do at, for example, an economic center.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More